SCHEMBL3072669

SCHEMBL3072669

COc1ccc(C2(c3ccc(O)c(C)c3)C(=O)Nc3c2ccc(F)c3F)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.48
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
LMNA P02545 2/20 0.48
XBP1 P17861 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
CNR1 P21554 1/20 0.42
HTT P42858 1/20 0.42
GPR35 Q9HC97 1/20 0.42
GPR55 Q9Y2T6 1/20 0.42
ESR1 P03372 2/20 0.37
ESR2 Q92731 2/20 0.37
POLB P06746 3/20 0.34
CASP6 P55212 1/20 0.34
HSD17B1 P14061 2/20 0.34
HSD17B2 P37059 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
BRD4 O60885 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3089808 0.89 CNR1 (0.54) MAPTMEN1KMT2ALMNAXBP1
SCHEMBL3202505 0.86 CNR1 (0.50) MAPTCNR1HTTGPR35GPR55
SCHEMBL3076602 0.85 CNR1 (0.44) MAPTCNR1HTTGPR35GPR55
SCHEMBL15630035 0.81 CNR1 (0.32) MAPTMEN1KMT2ALMNACNR1
SCHEMBL3076606 0.78 CNR1 (0.55) MAPTMEN1KMT2ALMNAXBP1
SCHEMBL31003780 0.78 CNR1 (0.34) MAPTMEN1KMT2ALMNAXBP1
SCHEMBL23983189 0.76 CNR1 (0.63) MAPTMEN1KMT2ALMNAXBP1
Hydrochloric Acid SCHEMBL3208081 0.76 MAPT (0.38) MAPTMEN1KMT2ACNR1HTT
Hydrochloric Acid SCHEMBL3208085 0.76 MAPT (0.38) MAPTMEN1KMT2ACNR1HTT
SCHEMBL29385169 0.76 GPR55 (0.56) MAPTMEN1KMT2ALMNAXBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100227863-A1 SUBSTITUTED 3-(4-HYDROXYPHENYL)-INDOLIN-2-ONE COMPOUNDS TOPOTARGET A/S (DK) 2010-09-09 US disclosed
US-20100227863-A1 SUBSTITUTED 3-(4-HYDROXYPHENYL)-INDOLIN-2-ONE COMPOUNDS TOPOTARGET A/S (DK) 2010-09-09 US disclosed
US-20100227863-A1 SUBSTITUTED 3-(4-HYDROXYPHENYL)-INDOLIN-2-ONE COMPOUNDS TOPOTARGET A/S (DK) 2010-09-09 US disclosed
WO-2008129075-A1 SUBSTITUTED 3-(4-HYDROXYPHENYL)-INDOLIN-2-ONE-COMPOUNDS TOPOTARGET A/S (DK) 2008-10-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100227863-A1 SUBSTITUTED 3-(4-HYDROXYPHENYL)-INDOLIN-2-ONE COMPOUNDS TPH2, TPH1, HTR2C MAPT 2199/4885MEN1 1624/4885KMT2A 2237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.